Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma.
Zhou J, Wu Z, Zhang Z, Goss L, McFarland J, Nagaraja A, Xie Y, Gu S, Peng K, Zeng Y, Zhang X, Long H, Nakagawa H, Rustgi A, Diehl JA, Meyerson M, Wong KK, Bass A.
Zhou J, et al.
Gut. 2022 Apr;71(4):665-675. doi: 10.1136/gutjnl-2020-323276. Epub 2021 Mar 31.
Gut. 2022.
PMID: 33789967
Free PMC article.